Skip to main content

Month: April 2022

CORRECTING and REPLACING — InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)

Fourth quarter 2021 Revenue and Adjusted EBITDA2 of $33 million and $9 million, representing an increase of almost 200% and 140% YoY, respectively Record fiscal year 2021 revenue and Adjusted EBITDA2 of $89 million and $23 million, representing an increase of over 230% and of almost 250% YoY, respectively Estimated net income of $5 million for 2021 Strong balance sheet with $89 million cash Six consecutive quarters with positive cash flow from operations Revenue growth expected to continue in the first quarter and throughout 2022 NEW YORK, TORONTO, and HERZLIYA, Israel, April 04, 2022 (GLOBE NEWSWIRE) — In a release published under the same headline earlier today by InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), please note that the monetary units in the tables should be Canadian dollars, not New Israeli Shekels as...

Continue reading

Advanced Human Imaging concludes Formal Agreements with Singapore based BizBaz Pte Ltd

SOUTH PERTH, Australia, April 04, 2022 (GLOBE NEWSWIRE) — Advanced Human Imaging Limited (ASX, NASDAQ: AHI) is pleased to update shareholders of the completion of the Master Services Agreement (“MSA” or “agreement”) with Singapore based digital health and financial intelligence platform BIZBAZ Pte Ltd (“BizBaz”). The parties have executed the standard AHI MSA which entails the legal and contractual terms in which AHI agrees to grant BizBaz the right to use AHI’s licensed Software Development Kits (SDKs) for IOS and Android platforms for body circumference measurements, face scan measurements and related intellectual property once integrated into the BizBaz application/platform. The MSA incorporates the following information and guidelines: commercial undertakings, software development kit, end user license, technology support,...

Continue reading

Nobel Provides Drill Results From Initial Program, La Salvadora Copper Project, Chile

Figure 1 Location of the Salvadora project.Figure 2 Location map showing the La Salvadora Project as well as major projects and operationsin the region.Figure 3 Location of the two target areas and drill holes at La Salvadora Project.TORONTO, April 04, 2022 (GLOBE NEWSWIRE) — Nobel Resources Corp. (TSX–V: NBLC; OTC: NBTRF) (the “Company” or “Nobel”) has received assays for 10 drill holes from its initial diamond drill program on its recently acquired Salvadora copper project in Chile (the “Project”) (see Table 1 below).   Copper mineralization has been intersected in all drill holes, including significant intervals grading more than 1% copper. Drill holes are located within two areas of the Project (Figure 3). Mineralization in both areas remains open. Results obtained to date have confirmed the discovery of a significant...

Continue reading

BW Offshore: Interim contract extension for Espoir Ivoirien

Interim contract extension for Espoir Ivoirien BW Offshore has entered into a short-term extension for Espoir Ivoirien from 4 April to 15 May 2022 to allow time to finalise terms for a further contract extension. For further information, please contact:Ståle Andreassen, CFO, +65 97 27 86 47Anders S. Platou, Head of Corporate Finance & Strategy, +47 99 50 47 40 IR@bwoffshore.com or www.bwoffshore.com About BW Offshore:BW Offshore engineers innovative floating production solutions. The Company has a fleet of 12 FPSOs with potential and ambition to grow. By leveraging four decades of offshore operations and project execution, the Company creates tailored offshore energy solutions for evolving markets world-wide. BW Offshore has around 2,000 employees and is publicly listed on the Oslo Stock Exchange. This information is subject to the...

Continue reading

Matterport to Showcase the Power of Digital Twins for Retail at Space Jam Event

Virtual competition pitches retail solutions from Matterport app developers and partners that improve merchandising, space planning, and e-commerce traffic SUNNYVALE, Calif., April 04, 2022 (GLOBE NEWSWIRE) — Matterport, Inc. (Nasdaq: MTTR), the leading spatial data company driving the digital transformation of the built world, today announced it will host the next installment of the Matterport Space Jam virtual event series, featuring five of its app developers that are building software solutions on the Matterport platform for retailers. The event will take place on April 28 at 8:30 am PT, offering attendees an opportunity to learn how five Matterport app developers and partners build solutions that enhance the value of Matterport digital twins for retail businesses. During the event, each Matterport app developer will demonstrate...

Continue reading

Innovative Payment Solutions, Inc. Launches Second Phase of IPSIPay App with Approval for its VISA Debit Card

CARMEL BY THE SEA, Calif., April 04, 2022 (GLOBE NEWSWIRE) — Innovative Payment Solutions, Inc. (OTCQB: IPSI) (“IPSI” or the “Company”), a fintech provider of digital payment solutions and services to businesses and consumers, including IPSIPay™, announces the second-phase launch of its IPSIPay App following approval from VISA® for use of its debit card services as part of IPSIPay. Following the initial launch of IPSIPay in December 2021, the availability of VISA debit card capability as part of IPSIPay enhances IPSIPay’s positioning as an attractive mobile banking solution for IPSI’s initial target market — the large and growing unbanked, under banked and money remittance market. The new IPSIPay VISA debit cards may be obtained via the IPSIPay App, enabling users to conduct transactions anywhere VISA is accepted globally....

Continue reading

Kona Gold Beverage, Inc. Posts First Million Dollar Quarter

Company recorded revenues of approximately $400,000 in the month of March Melbourne, FL, April 04, 2022 (GLOBE NEWSWIRE) — Kona Gold Beverage, Inc. (OTC Pink: KGKG), a holding company focused on product development in the better-for-you and hemp and CBD functional beverage sector, is pleased to announce the Company had revenues of over one million dollars in the first quarter of 2022.  This marks the Company’s first quarter of one million dollars or more, which is a huge milestone and testament to the continued growth it’s experiencing.  Kona Gold Beverages two subsidiaries, Kona Gold LLC and Gold Leaf Distribution LLC’s combined revenue broke the one-million-dollar mark in Q1. Gold Leaf Distribution, the Company’s distribution subsidiary, continues to have record month-over-month revenue and March was no exception.  March revenue...

Continue reading

Medigus Announces Final Airworthiness Criteria Published by the FAA

Leading drone company using ParaZero’s SafeAir™ system is heading towards completing final regulatory process of type certification with the U.S. Federal Aviation Administration (FAA) Tel Aviv, Israel, April 04, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that ParaZero Ltd. (“ParaZero“), a privately held company engaged in drone technology with an innovative patented safety system for drones, of which Medigus has a 40% ownership stake, confirmed that leading drone manufacturer, Airobotics, is proceeding towards type certification of its automated drone system after final airworthiness criteria was published by the U.S. Federal Aviation Administration...

Continue reading

Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants

New York, NY, and Tel Aviv, ISRAEL, April 04, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. announced that its mechanism-based 3CL protease inhibitors Tollovir® and Tollovid™ that target the active site of the 3CL protease showed robust inhibitory activity against the 3CL protease of the BA.1 and BA.2 strains of the Omicron SARS-CoV-2 variant of concern (VOC). Additionally, Tollovir and Tollovid showed inhibitory activity against the original wild-type SARS-CoV-2 strain, as well as the Alpha, Beta, Delta and Gamma VOCs. The results showed IC50 binding affinity of

Continue reading

Trident Brands Announces Authorization of Preferred Stock to Complete Planned Debt Reduction

Issuance of Preferred Shares will be in Satisfaction of Approximately $17.7 Million of Debt Boca Raton, FL, April 04, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Trident Brands Incorporated (OTCQB: TDNT), a nutraceutical company, today announced that it has filed an amendment to its certificate of incorporation to authorize 29,320,432 shares of Preferred Stock which it will use, pursuant to its previously announced agreement with the note holder, to satisfy approximately $17.7 Million of principal and accrued interest due under certain convertible notes, representing a conversion rate of $0.60 per share. The amendment authorizing the Preferred Shares was approved by a majority of the Company’s shareholders and was filed with the State of Nevada on March 31, 2022. The amendment will be effective May 31, 2022, subject to the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.